Skip to main content
Top
Published in: Tumor Biology 4/2014

01-04-2014 | Research Article

Genetic variations at microRNA and processing genes and risk of oral cancer

Authors: Roshni Roy, Navonil De Sarkar, Sandip Ghose, Ranjan R. Paul, Mousumi Pal, Chandrika Bhattacharya, Shweta K Roy Chowdhury, Saurabh Ghosh, Bidyut Roy

Published in: Tumor Biology | Issue 4/2014

Login to get access

Abstract

Genetic variations at microRNA and microRNA processing genes are known to confer risk of cancer in different populations. Here, we studied variations at eight microRNA (miRNA) and four miRNA processing genes in 452 controls and 451 oral cancer patients by TaqMan genotyping assays. Variant allele-containing genotypes at mir-196a2 and variant allele homozygous genotype at Ran increased the risk of cancer significantly [adjusted odds ratio (OR) (95 % confidence interval (CI)) = 1.3 (1–1.7) and 2.3 (1.1–4.6), respectively]. Conversely, variant allele-containing genotypes at mir-34b and variant allele homozygous genotype at Gemin3 reduced the risk of cancer significantly [adjusted OR (95 % CI) = 0.7 (0.5–0.9) and 0.6 (0.4–1), respectively]. Cumulative risk was also increased by three times with increase in the number of risk alleles at these four loci. In tobacco stratified analysis, variant allele homozygous genotypes at mir-29a and Ran increased [adjusted OR (95 % CI) = 1.5 (1–2.3) and 3 (1.1-8.4) respectively], while variant allele-containing genotypes at mir-34b decreased [adjusted OR (95 % CI) = 0.6 (0.4–0.9)] the risk of cancer significantly. Thus, genetic variation at miRNA and processing genes altered the risk of oral cancer in this population thereby corroborating studies in other populations. However, it is necessary to validate this result in different Indian sub populations with larger sample sizes and examine the effect of these variations in tumour tissues to explain the mechanism of risk alteration.
Literature
1.
go back to reference Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7(1):108–12.PubMed Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7(1):108–12.PubMed
2.
5.
7.
go back to reference Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931–4.PubMedCrossRef Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931–4.PubMedCrossRef
8.
go back to reference Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376–85.PubMedCrossRef Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376–85.PubMedCrossRef
11.
go back to reference Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer. 2007;120(10):2148–56. doi:10.1002/ijc.22547.PubMedCrossRef Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer. 2007;120(10):2148–56. doi:10.​1002/​ijc.​22547.PubMedCrossRef
12.
15.
16.
go back to reference Chen D, Cabay RJ, Jin Y, Wang A, Luo Y, Shah-Khan M et al. MicroRNA deregulations in head and neck squamous cell carcinomas. J Oral Maxillofac Res. 2013; 4(1). doi:10.5037/jomr.2013.4102. Chen D, Cabay RJ, Jin Y, Wang A, Luo Y, Shah-Khan M et al. MicroRNA deregulations in head and neck squamous cell carcinomas. J Oral Maxillofac Res. 2013; 4(1). doi:10.​5037/​jomr.​2013.​4102.
20.
go back to reference Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289–300. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289–300.
21.
go back to reference Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59(8):2068–74. doi:10.2337/db09-1386.PubMedCentralPubMedCrossRef Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59(8):2068–74. doi:10.​2337/​db09-1386.PubMedCentralPubMedCrossRef
22.
go back to reference Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer. 2003;105(5):681–6. doi:10.1002/ijc.11114.PubMedCrossRef Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer. 2003;105(5):681–6. doi:10.​1002/​ijc.​11114.PubMedCrossRef
25.
go back to reference Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128(2):412–7. doi:10.1002/ijc.25342.PubMedCrossRef Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128(2):412–7. doi:10.​1002/​ijc.​25342.PubMedCrossRef
27.
28.
go back to reference Li YC, Song CH, Yang WJ, Dai LP, Wang P, Shi JX, et al. [Correlation between tag single nucleotide polymorphisms of microRNA regulatory genes and the genetic susceptibility of primary liver cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(6):533–7.PubMed Li YC, Song CH, Yang WJ, Dai LP, Wang P, Shi JX, et al. [Correlation between tag single nucleotide polymorphisms of microRNA regulatory genes and the genetic susceptibility of primary liver cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(6):533–7.PubMed
29.
go back to reference Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009;45(17):3104–18. doi:10.1016/j.ejca.2009.09.014.PubMedCrossRef Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009;45(17):3104–18. doi:10.​1016/​j.​ejca.​2009.​09.​014.PubMedCrossRef
Metadata
Title
Genetic variations at microRNA and processing genes and risk of oral cancer
Authors
Roshni Roy
Navonil De Sarkar
Sandip Ghose
Ranjan R. Paul
Mousumi Pal
Chandrika Bhattacharya
Shweta K Roy Chowdhury
Saurabh Ghosh
Bidyut Roy
Publication date
01-04-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1450-3

Other articles of this Issue 4/2014

Tumor Biology 4/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine